Skip to main content
SpringerLink
Log in

Ramipril appears to reduce the incidence of cardiac events in patients with angina pectoris who have asymptomatic, moderate left ventricular dysfunction and who have undergone invasive revascularisation

  • Clinical study
  • Published:
Inpharma Weekly

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ramipril appears to reduce the incidence of cardiac events in patients with angina pectoris who have asymptomatic, moderate left ventricular dysfunction and who have undergone invasive revascularisation. Inpharma Wkly. 1236, 18 (2000). https://doi.org/10.2165/00128413-200012360-00043

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00128413-200012360-00043

Keywords

Search

Navigation